Bill Search

  • Introduced
    Jan 18, 2023
  • Passed Assembly
    Jun 06, 2023
  • Passed Senate
    Jun 06, 2023
  • Signed into Law
    Dec 22, 2023
A 1707
New York Assembly Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs
Last Action See all actions
Assembly • Dec 22, 2023: SIGNED CHAP.738
Latest Bill Text See all bill texts

Official Summary/Bill Text

Comments on A 1707

Tweets

Whip Lists

Sponsors
Actions
  • Dec 22, 2023 | Assembly
    • SIGNED CHAP.738
  • Dec 12, 2023 | Assembly
    • DELIVERED TO GOVERNOR
  • Jun 06, 2023 | Senate
    • REFERRED TO RULES
    • SUBSTITUTED FOR S599A
    • 3RD READING CAL.75
    • PASSED SENATE
    • RETURNED TO ASSEMBLY
  • Jun 06, 2023 | Assembly
    • PASSED ASSEMBLY
    • DELIVERED TO SENATE
  • May 30, 2023 | Assembly
    • SUBSTITUTION RECONSIDERED
    • RESTORED TO THIRD READING
    • AMENDED ON THIRD READING 1707A
  • May 15, 2023 | Assembly
    • SUBSTITUTED BY S599
  • May 11, 2023 | Assembly
    • ADVANCED TO THIRD READING CAL.196
  • May 09, 2023 | Assembly
    • REPORTED
  • Apr 26, 2023 | Assembly
    • REPORTED REFERRED TO CODES
  • Feb 08, 2023 | Assembly
    • REFERENCE CHANGED TO INSURANCE
  • Jan 18, 2023 | Assembly
    • REFERRED TO HEALTH
Documents
Looks like we don't have any documents available at this moment.